Invictus acting CEO Kane to focus on sales, new products
Invictus Medical’s acting CEO Dennis Kane, who took the reins earlier this month from foundational CEO Tom Roberts, is already leading the development of a new activity sensor to integrate into its flagship GelShield device.
The device is designed as a headband to be placed around newborn baby’s heads to prevent pressure from building in the skull.
The company will be seeking regulatory approval for the product in the next year, according to a report from Xconomy.
Invictus is still seeking its 1st orders of the GelShield, which won FDA clearance in May last year, and said it has “a few potential hospital clients,” according to the report.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.